ACE2 News and Research

RSS
COVID-19 during pregnancy shows no affect on placental structure and pathology

COVID-19 during pregnancy shows no affect on placental structure and pathology

De novo designed SARS-CoV-2 nanoparticle vaccine

De novo designed SARS-CoV-2 nanoparticle vaccine

Experimental COVID-19 vaccine prevents severe disease in mice

Experimental COVID-19 vaccine prevents severe disease in mice

Membrane nanoparticles acts as a bait to trap SARS-CoV-2

Membrane nanoparticles acts as a bait to trap SARS-CoV-2

Synthetic nanobodies prevent SARS-CoV-2 infection

Synthetic nanobodies prevent SARS-CoV-2 infection

Cardiovascular disease in COVID-19

Cardiovascular disease in COVID-19

C-type lectin receptors play a role in SARS-CoV-2 infection

C-type lectin receptors play a role in SARS-CoV-2 infection

Study reveals new clues about SARS-CoV-2 infection

Study reveals new clues about SARS-CoV-2 infection

Research looks at convalescent plasma use in COVID-19 mouse model

Research looks at convalescent plasma use in COVID-19 mouse model

SARS-CoV-2 a "swarm" of mutant viruses

SARS-CoV-2 a "swarm" of mutant viruses

Scientist explains why COVID-19 targets only some organs while others are spared

Scientist explains why COVID-19 targets only some organs while others are spared

Inhaled delivery of a potent neutralizing nanobody effective against SARS-CoV-2

Inhaled delivery of a potent neutralizing nanobody effective against SARS-CoV-2

SARS-CoV-2 infection and transmission possible in North American deer mice

SARS-CoV-2 infection and transmission possible in North American deer mice

Novel coronavirus does not directly damage taste bud cells, UGA study shows

Novel coronavirus does not directly damage taste bud cells, UGA study shows

NIH awards $1.2 million grant to create humanized mice susceptible to COVID-19

NIH awards $1.2 million grant to create humanized mice susceptible to COVID-19

DHODH inhibitor PTC299 shows potential as a COVID-19 therapeutic

DHODH inhibitor PTC299 shows potential as a COVID-19 therapeutic

Speed of Novavax vaccine development does not compromise quality of the SARS-CoV-2 immunogen

Speed of Novavax vaccine development does not compromise quality of the SARS-CoV-2 immunogen

Cutting edge synthetic peptides block SARS-CoV-2 (COVID-19)

Cutting edge synthetic peptides block SARS-CoV-2 (COVID-19)

SARS-CoV-2 may not be targeting taste bud cells

SARS-CoV-2 may not be targeting taste bud cells

A SARS-CoV-2 assay using plant proteins

A SARS-CoV-2 assay using plant proteins